Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 9
Submit an article Journal homepage
202
Views
3
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro

D. ChenDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
X.-X. LinDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
Q. ZhaoDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
J. XiaoDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China,
,
S.-F. PengDepartment of Hepatology and Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China, and ;Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, China
,
M.-F. XiaoDepartment of Hepatology and Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China, and ;Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, China
,
D.-S. OuyangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
Z.-R. TanDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
Y.-C. WangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
J.-B. PengDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
,
W. ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China,
&
Y. ChenDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China, ;Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, China, Correspondence[email protected]
 show all
Pages 778-784 | Received 18 Jul 2016, Accepted 27 Aug 2016, Published online: 15 Nov 2016

References

  • Bourrie M, Meunier V, Berger Y, Fabre G. (1996). Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277:321–32
  • Brown NM, Reeves DS, McMullin CM. (1997). The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either hemodialysis or continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 39:803–9
  • Burtenshaw AJ, Sellors G, Downing R. (2008). Presumed interaction of fusidic acid with simvastatin. Anaesthesia 63:656–8
  • Chen J, Zhao KN, Chen C. (2014). The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis. Ann Transl Med 2:7
  • Cornish-Bowden A. (1974). A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J 137:143–4
  • Goey AK, Mooiman KD, Beijnen JH, et al. (2013). Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb–drug interactions in cancer patients. Cancer Treat Rev 39:773–83
  • Huang X, Guo Y, Huang WH, et al. (2014). Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San. PLoS One 9:e113819
  • Kraus CN, Burnstead BW. (2011). The safety record of fusidic acid in non-US markets: a focus on skin infections. Clin Infect Dis 52:S527–37
  • Li X, Wang K, Wei W, et al. (2013). In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates. Chem Biol Interact 204:140–3
  • Magee CN, Medani SA, Leavey SF, et al. (2010). Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. Am J Kidney Dis 56:e11–15
  • Niwa T, Shiraga T, Hashimoto T, Kagayama A. (2004). Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes. Biol Pharm Bull 27:97–9
  • Peter JD, Jehl F, Pottecher T, et al. (1993). Pharmacokinetics of intravenous fusidic acid in patients with cholestasis. Antimicrob Agents Chemother 37:501–6
  • Qin CZ, Ren X, Tan ZR, et al. (2014). A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 28:197–203
  • Reeves DS. (1987). The pharmacokinetics of fusidic acid. J Antimicrob Chemother 20:467–76
  • Sevrioukova IF, Poulos TL. (2013). Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems. Dalton Trans 42:3116–26
  • Still JG, Clark K, Degenhardt TP, et al. (2011). Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects. Clin Infect Dis 52:S504–12
  • Taavitsainen P, Juvonen R, Pelkonen O. (2001). In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab Dispos 29:217–22
  • Teckchandani S, Robertson S, Almond A, et al. (2010). Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin. J R Coll Physicians Edinb 40:33–6
  • Tsuji BT, Okusanya OO, Bulitta JB, et al. (2011). Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead. Clin Infect Dis 52:S513–9
  • Turnidge J. (1999). Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 12:S23–34
  • Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.